Kate Chapman

Background

About Kate Chapman

Kate Chapman is the Director of Clinical Technology Consultants and the Principal Consultant. Before forming Clinical Technology Consultants Ltd, she gained 19 years of experience in the Clinical Development area of the Pharmaceutical and Biotechnology sector, with a special interest in IRT. In that time Kate worked with and for companies ranging through; Sandoz, Novartis, Innovex, Roche, Bristol Myers Squibb, Sanofi, Merck, Sharpe and Dohme, Pharmacia, PPD and Emergent Biosciences. Kate formed and led an internal support function dedicated to IRT services and associated disciplines for Shire Pharmaceuticals. Kate has extensive experience as an end-user of IRT systems and has reviewed, in depth, a large number of the systems that are currently available from a wide variety of third party IRT providers. Kate is also an expert at planning and scripting User Acceptance Tests that meet the risk profile of any sponsor/vendor partnership and is skilled at leading inexperienced testing teams through a happy and efficient testing experience. Kate is in demand as a speaker and panellist at conferences covering Europe and North America discussing topics specific to the IRT arena such as; selection of preferred partner companies, internal standardisation, vendor relationship optimisation and emerging mobile technologies. Due to her background in Clinical Development her focus is very much on the needs of the project manager, sites and subjects, but with a broad understanding of the related disciplines of Clinical Supply Management, Data Management and statistically driven data transfer requirements.